Increased bone resorption by long-term cigarette smoke exposure in animal model

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Citação
HELIYON, v.7, n.12, article ID e08587, 10p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Clinical and experimental studies have been attesting the deleterious effects of smoking mainly due to the stimulation of osteoclastogenesis and inhibition of osteoblastogenesis. However the physiological mechanisms that can explain these changes are not fully understood. Aims: To evaluate the trabecular bone resorption effect caused by long-term exposure to cigarette smoke and the action of cytokines and reactive oxygen species involved in this process. Methods: Sixty young adult C57BL/6 mice were allocated to two groups: control, 30 animals exposed to filtered air for 1, 3 and 6 months; and smoke, 30 animals exposed to cigarette smoke for 1, 3 and 6 months. Femoral and tibial extraction was performed to evaluate the bone mineral matrix, bone cytokines (Receptor activator of nuclear factor-kappa B ligand -RANKL and Osteoprotegerin -OPG) and oxidative stress markers (Thiobarbituric acid reactive substances -Tbars). Results: Exposure to cigarette smoke (CS) generated changes in bone structural parameters in the 6th month of follow-up, demonstrating an evident bone loss; reduction in OPG/RANKL ratio from the 3rd month on and increase in Tbars in the first month, both closely related to the increase in osteoclastogenic activity and bone resorption. Conclusion: These findings reinforce the importance of CS-induced oxidative stress in bone compromising the bone cellular activities with a consequent impairment in bone turn over and changes in bone structure.
Palavras-chave
Smoking, Bone remodeling, Bone matrix, Oxidative stress
Referências
  1. Altindag O, 2008, RHEUMATOL INT, V28, P317, DOI 10.1007/s00296-007-0452-0
  2. [Anonymous], 2011, COMM UPD GUID CAR U, Veighth
  3. Bai P, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-157
  4. Bai XC, 2005, J BIOL CHEM, V280, P17497, DOI 10.1074/jbc.M409332200
  5. Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073
  6. Barbosa AP, 2020, LIFE SCI, V241, DOI 10.1016/j.lfs.2019.117132
  7. BROULIK PD, 1993, HORM METAB RES, V25, P219, DOI 10.1055/s-2007-1002080
  8. Callaway DA, 2015, J BONE MINER METAB, V33, P359, DOI 10.1007/s00774-015-0656-4
  9. Castrogiovanni P, 2016, HISTOL HISTOPATHOL, V31, P1183, DOI 10.14670/HH-11-793
  10. DANIELL HW, 1976, ARCH INTERN MED, V136, P298, DOI 10.1001/archinte.136.3.298
  11. Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
  12. DIFFORD J, 1974, MED LAB TECHNOL, V31, P79
  13. ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407
  14. Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3
  15. GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485
  16. Henemyre CL, 2003, J PERIODONTOL, V74, P1440, DOI 10.1902/jop.2003.74.10.1440
  17. Kamer AR, 2006, INT J MOL MED, V17, P121
  18. Kulak CAM, 2010, J BONE MINER RES, V25, P1931, DOI 10.1002/jbmr.88
  19. Lappin DF, 2007, J CLIN PERIODONTOL, V34, P271, DOI 10.1111/j.1600-051X.2007.01048.x
  20. Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021
  21. Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662
  22. LOWRY OH, 1951, J BIOL CHEM, V193, P265
  23. Mescher A, 2016, HISTOLOGY BASIC JUNQ, Vfourteenth
  24. Pearson RG, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010303
  25. Recker RR, 2011, BONE, V49, P955, DOI 10.1016/j.bone.2011.07.017
  26. Saha H, 2016, J APPL TOXICOL, V36, P969, DOI 10.1002/jat.3275
  27. Sasaki M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191611
  28. Siddiqui JA, 2016, PHYSIOLOGY, V31, P233, DOI 10.1152/physiol.00061.2014
  29. Talhout R, 2011, INT J ENV RES PUB HE, V8, P613, DOI 10.3390/ijerph8020613
  30. Terpos E, 2003, BLOOD, V102, P1064, DOI 10.1182/blood-2003-02-0380
  31. Toledo AC, 2012, EUR RESPIR J, V39, P254, DOI 10.1183/09031936.00003411
  32. Ugay L, 2016, CHINESE MED J-PEKING, V129, P1696, DOI 10.4103/0366-6999.185857
  33. van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468
  34. Wauquier F, 2009, TRENDS MOL MED, V15, P468, DOI 10.1016/j.molmed.2009.08.004
  35. Xu SQ, 2012, RHEUMATOL INT, V32, P3397, DOI 10.1007/s00296-011-2175-5
  36. Zhang PF, 2013, COPD, V10, P650, DOI 10.3109/15412555.2013.813928